XIAP and inflammatory bowel disease: Early functional and genetic testing for XIAP deficiency, especially in children who are difficult to treat with CD and VEO-IBD, might be an additional strategy to anticipate, and possibly prevent severe morbidity related to EBV infection [26,27].